- Home
- BODI vs LTRN Comparison
BODI vs LTRN Comparison
Compare BODI & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- LTRN
- Stock Information
- Founded
- BODI 1998
- LTRN 2013
- Country
- BODI United States
- LTRN United States
- Employees
- BODI N/A
- LTRN N/A
- Industry
- BODI Industrial Machinery/Components
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- LTRN Health Care
- Exchange
- BODI Nasdaq
- LTRN Nasdaq
- Market Cap
- BODI 38.8M
- LTRN 33.7M
- IPO Year
- BODI N/A
- LTRN 2020
- Fundamental
- Price
- BODI $6.51
- LTRN $3.69
- Analyst Decision
- BODI Strong Buy
- LTRN Hold
- Analyst Count
- BODI 3
- LTRN 1
- Target Price
- BODI $12.33
- LTRN N/A
- AVG Volume (30 Days)
- BODI 17.4K
- LTRN 68.3K
- Earning Date
- BODI 03-10-2025
- LTRN 03-17-2025
- Dividend Yield
- BODI N/A
- LTRN N/A
- EPS Growth
- BODI N/A
- LTRN N/A
- EPS
- BODI N/A
- LTRN N/A
- Revenue
- BODI $451,432,000.00
- LTRN N/A
- Revenue This Year
- BODI N/A
- LTRN N/A
- Revenue Next Year
- BODI N/A
- LTRN N/A
- P/E Ratio
- BODI N/A
- LTRN N/A
- Revenue Growth
- BODI N/A
- LTRN N/A
- 52 Week Low
- BODI $5.14
- LTRN $2.79
- 52 Week High
- BODI $12.13
- LTRN $11.99
- Technical
- Relative Strength Index (RSI)
- BODI 51.94
- LTRN 52.87
- Support Level
- BODI $5.45
- LTRN $3.45
- Resistance Level
- BODI $7.50
- LTRN $3.97
- Average True Range (ATR)
- BODI 0.58
- LTRN 0.46
- MACD
- BODI 0.04
- LTRN -0.00
- Stochastic Oscillator
- BODI 51.71
- LTRN 37.00
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in two operating segments, Beachbody and Other.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.